每經AI快訊，12月12日，中(zhong)(zhong)(zhong)恒(heng)(heng)集(ji)團公告(gao)，公司(si)全(quan)資(zi)子(zi)公司(si)中(zhong)(zhong)(zhong)恒(heng)(heng)怡鑫擬與申萬宏(hong)(hong)源集(ji)團、宏(hong)(hong)源匯(hui)富、廣西(xi)投資(zi)引導基金(jin)有限責任公司(si)共同(tong)參與投資(zi)設立申宏(hong)(hong)中(zhong)(zhong)(zhong)恒(heng)(heng)(廣西(xi))健康(kang)(kang)產業股(gu)權(quan)投資(zi)合(he)伙(huo)企業(有限合(he)伙(huo))，重點圍繞生(sheng)物醫藥、醫療器械、醫療服務、健康(kang)(kang)食品及健康(kang)(kang)消費等(deng)相關(guan)領域開展(zhan)股(gu)權(quan)投資(zi)。合(he)伙(huo)企業認繳(jiao)出資(zi)總額(e)為(wei)5億元，中(zhong)(zhong)(zhong)恒(heng)(heng)怡鑫將作為(wei)有限合(he)伙(huo)人認繳(jiao)出資(zi)額(e)為(wei)2.45億元，占比49%。